We characterized 70 consecutive patients with cryptogenic cirrhosis to asse
ss major risks for liver disease. Each patient was reevaluated for past alc
ohol exposure, scored by the International Autoimmune Hepatitis (IAH) score
and assessed for viral hepatitis risks and risks for nonalcoholic steatohe
patitis (NASH). The results were compared with 50 consecutive NASH patients
, 39 nonalcoholic patients age SO and over with cirrhosis from hepatitis C,
and 33 consecutive patients with cirrhosis caused by primary biliary cirrh
osis (PBC), Among the cryptogenic group, 49 (70%) were female, and the mean
age was 63 +/- 11 years. Although ascites and variceal bleeding were commo
n, almost one half lacked major signs of complicated portal hypertension. A
history of Type 2 diabetes mellitus and/or obesity was present in 51 (73%)
, Nineteen (27%) patients had a history of blood transfusions antedating th
e diagnosis of cirrhosis, No clinical or histological features distinguishe
d this group from the other patients, and 14 (74%) of these had a history o
f obesity and/or diabetes. Nineteen of the remaining nontransfused patients
had indeterminant IAH scores but were histologically and biochemically ind
istinguishable from the others. Twelve of these (63%) also had a history of
obesity and/or diabetes. Both diabetes and obesity were significantly more
common in the cryptogenic cirrhotic patients compared with the cirrhotic p
atients with PBC or hepatitis C, In contrast, the prevalence of obesity and
diabetes was similar to the NASH patients who were, on average, a decade y
ounger. Although there is some diversity that indicates more than one cause
, our findings suggest that NASH plays an under-recognized role in many pat
ients with cryptogenic cirrhosis, most of whom are older, type 2 diabetic a
nd obese females.